Uri Maoz has long pondered the nature of decision-making, questioning if we truly choose or are merely reacting. His research now delves into the neural pathways that transform beliefs and desires into actions.

In a twist of nomenclature, Moderna’s mRNA technology is being rebranded from 'vaccine' to 'therapy,' aiming to avoid vaccine-related fear. This wordplay highlights how terminology can shape public perception, even in scientific contexts.

Meanwhile, Sam Altman's home has faced two near-attacks in as many days, raising questions about AI safety and growing societal divides on the subject. As AI technologies advance, so do their risks.

The world of biotech is also evolving rapidly, with countries racing to integrate AI into military systems, and firms like OpenAI facing potential legal battles over their technology's deployment.